Friday, 21 June 2019

FDA approves drug for loss of sexual desire in premenopausal women

The U.S. Food and Drug Administration on Friday approved Palatin Technologies Inc and Amag Pharmaceuticals Inc's drug to restore sexual desire in premenopausal women.


No comments:

Post a Comment